logo
  

General Mills Initiates FY23 Outlook; Boosts Qtly Dividend 6% - Update

While reporting financial results for the fourth quarter and fiscal 2022 on Wednesday, branded food company General Mills, Inc. (GIS) initiated constant-currency adjusted earnings per share and organic net sales growth guidance for the full-year 2023.

General Mills said it expects the largest factors impacting its performance in fiscal 2023 to be the economic health of consumers, the inflationary cost environment, and the frequency and severity of disruptions in the supply chain.

The company also estimates the net impact of a series of portfolio reshaping transactions to reduce fiscal 2023 adjusted operating profit growth and adjusted earnings per share growth by approximately 3 percent each.

For fiscal 2023, the company now projects constant-currency adjusted earnings per share to range between flat and up 3 percent on organic net sales growth of 4 to 5 percent.

The Street is currently looking for earnings of $3.96 per share on revenue growth of 1.1 percent to $19.11 billion for the year.

The General Mills board of directors also declared a six percent higher quarterly dividend of $0.54 per share, payable August 1, 2022, to shareholders of record July 8, 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Integrated energy company Chevron reported Friday that profit for the fourth quarter increased 25 percent from last year, reflecting 17 percent revenue growth amid higher realizations and higher margins on refined product sales. Adjusted earnings per share missed analysts' estimates, while quarterly revenues topped it. Reno, Nevada-based ZLINE Kitchen and Bath has expanded its recall of gas ranges citing serious risk of injury or death from carbon monoxide poisoning, the U.S. Consumer Product Safety Commission announced. The recall now includes about 30,000 units of ZLINE gas ranges, including about 28,000 units... The Food and Drug Administration's independent advisory committee unanimously recommended replacing the current original COVID vaccines used in the U.S. for primary shots with new bivalent omicron shots authorized as boosters, reports said. The committee also considered the proposal for annual COVID vaccination, however, didn't vote on it.
Follow RTT